Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 74.50
-0.71 (-0.94%)
At close: Jan 22, 2026
Chengdu Kanghua Biological Products Company Description
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China.
It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines.
The company also develops seasonal influenza vaccines. In addition, it exports its products.
Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
Chengdu Kanghua Biological Products Co., Ltd.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 620 |
| CEO | Hongbo Wu |
Contact Details
Address: No. 182, Beijing Road Chengdu, 610100 China | |
| Phone | 86 28 8484 6555 |
| Website | kangh.com |
Stock Details
| Ticker Symbol | 300841 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003Y57 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hongbo Wu | President and Non-Independent Director |
| Wennian Wu | Vice President, Chief Financial Officer, Secretary of the Board and Director |
| Huaigong Chen | Vice President and Quality Manager |
| Fu Wang | Vice President |
| Ping Liu | Accounting Supervisor |